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Introduction
Autism	Spectrum	Disorder	(ASD)	is	a	complex	neurodevelopmental disorder characterized by 
impairments	in	social	communication	and	interac-
tion,	and	the	presence	of	restricted	and	repetitive	
interests. Intellectual Disability (ID) is a heteroge-
neous	condition	defined	by	significantly	sub-average	
intellectual	and	adaptive	functioning	with	onset	







non-social	aspects	of	the	environment.3 Over the 
years,	diagnostic	criteria	for	ASD	have	been	refined	
and the biological underpinnings of the syndrome 
are	better	understood.	According	to	the	Centers	for	
Disease Control (CDC), the prevalence of an ASD 















funded programs.6 Yearly health care expenditures 
for	a	child	with	ASD	are	estimated	to	be	8-9	times	
that	of	a	child	without	ASD.	Medication	expenses	
make	up	approximately	27%	of	this	cost.7 Because of 







Disorder, Pervasive Developmental Disorder Not 
Otherwise	Specified	(PDD	NOS),	Childhood	Disin-
tegrative	Disorder,	and	Rett’s	Disorder.8 Individuals 












Disorder, Asperger’s Disorder, and PDD NOS have 
been	collapsed	into	the	general	diagnosis	of	Autism	
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Risk and Protective Factors
The	etiology	of	ASD	is	known	in	only	a	portion	of	
cases. The syndrome is considered to be neurobiologi-
cal,	as	multiple	genes	have	been	identified	as	increas-
ing	an	individual’s	risk	for	ASD.	The	majority	of	these	
genes encode proteins that regulate synapse devel-
opment	and	activity-dependent	neural	responses.11 
There	is	also	evidence	that	certain	neurotransmitter	







syndromes do not have ASD, but rather, they have 























The presence or absence of ID, language impairment, 
and/or	comorbid	psychiatric	disorders	are	the	best	
identified	prognostic	factors	in	ASD.18 ID is generally 
34






















Pediatricians and other community health provid-
ers	are	typically	the	first	professionals	to	be	alerted	
to developmental concerns through parent report or 
direct	observation	of	a	child.	The	American	Academy	
of Pediatrics recommends that all children undergo 
screening	for	ASD	as	part	of	their	18-	and	24-month	











ID.24 Standardized screening instruments are impor-
tant	to	identify	children	with	developmental	disorders	
who	are	not	captured	through	clinical	observation	or	
parent report. Parents’ experiences and cultural dif-
ferences	in	child	rearing	practices	and	developmental	
expectations	contribute	to	differential	patterns	of	




The Modified Checklist for Autism in Toddlers	(M-






already carry the diagnosis.25	A	two-step	approach	
including	a	brief	standardized	follow-up	interview	
helps	to	reduce	false	positives.27	In	their	review,	Nor-






ity rates for younger children. Other instruments, 
including the Social Responsiveness Scale (SRS) and 








variety of systems (schools, mental health agencies, 












standard tool for diagnosing ASD.30	The	ADOS-2	uses	
semi-structured	play	activities	and	social	interactions	
to	create	situational	presses	for	social	initiations	and	













superior to a single measure in correctly classifying 
children	with	ASD.32
Other tools may be necessary to clarify the diag-
nostic	picture,	especially	when	observational	data	
and parent report are discrepant. Comprehensive 
measures	of	cognitive	ability	are	important	to	rule	
out	comorbid	ID	and	identify	specific	impairments	














samples. As a result, it is possible that children in 
these	groups	are	misidentified	or	under-identified	




process. Similar concerns exist regarding gender dif-
ferences.	Males	are	disproportionately	represented	in	
ASD research, including samples used to develop and 
















individual presents for a mental health assessment.23 
Ideally,	individuals	diagnosed	with	ASD	in	the	ab-






ered by insurance companies.36
Comorbid Conditions
Given	the	wide	range	of	developmental	impairment,	













nalizing behavioral symptoms), to the many possible 
underlying	contributing	factors.37	With	the	help	of	the	















and hence to under diagnose the presence of comor-
36









clear. All categories of psychiatric illness can present 
in	an	individual	with	ASD	or	ID,	with	mood	and	anxi-
ety disorders being the most common, and substance 






























and families across 17 sites in the United States and 
Canada. The goal of the ATN is for treatment provid-
ers	to	share	information	in	order	to	develop	a	set	of	
















psychotropic	medication.44 Even if a formal psychiatric 
diagnosis is not made, the range of serious symptoms 
including	agitation,	aggression,	and	self-injury	will	
necessitate	psychiatric	evaluation	and	management.	
The child and adolescent psychiatrist is called upon 
to	(1)	search	for	medical	causation	of	the	behavioral	
and	mood	symptoms,	refer	the	patient	to	pediatrics	













for comorbid psychiatric illness, controversy as to 
whether	to	study	comorbid	psychiatric	diagnoses	or	
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lants, alpha agonists, and mood stabilizers are fre-
quently used for treatment of behavioral problems in 
children	with	DD;	however,	there	have	been	few	ran-
domized	placebo-controlled	drug	studies	supporting	
their use.49 Anxiety disorders are the most common 
psychiatric	comorbidity	in	children	with	ASD,	yet	there	
have been no controlled trials of pharmacologic treat-
ment	of	anxiety	in	the	population.	The	studies	that	do	







increased stereotypy.50 There is some evidence that 
treatment	of	ADHD	symptoms	with	methylphenidate	
is	beneficial.	However,	treatment	effects	are	less	


















have empirical support. Applied behavior analysis 
(ABA)	strategies,	such	as	prompting,	reinforcement,	






















nology (voice output devices) and other materials 
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consequence chains can be altered to reduce problem 





































































visual details.69 These methods include structuring 










curacy and reduce the need for adult support among 
students	in	special	and	general	education	settings.71
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the state of Colorado.
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